Investment » Trang Công Nghệ | Trangcongnghe.vn

Monsha’at: Day 2 of Biban 2024 raises the bar for Saudi entrepreneurship with over 1.35bn Saudi Riyals worth of agreements launched

Globe Newswire

Monsha’at: Day 2 of Biban 2024 raises the bar for Saudi entrepreneurship with over 1.35bn Saudi Riyals worth of agreements launched

Bitget and Foresight Ventures Invest $30 Million in TON Blockchain to Accelerate Growing Telegram-based Projects

Globe Newswire

Bitget and Foresight Ventures Invest $30 Million in TON Blockchain to Accelerate Growing Telegram-based Projects

David Barrett, CEO of EBC Financial Group (UK) Ltd and EBC Financial Group (Cayman) Limited, Analyses Global Market Volatility, High-Interest Rate Pressures, and Safe-Haven Investment Strategies Amid 2024 Economic Shifts

Globe Newswire

David Barrett, CEO of EBC Financial Group (UK) Ltd and EBC Financial Group (Cayman) Limited, Analyses Global Market Volatility, High-Interest Rate Pressures, and Safe-Haven Investment Strategies Amid 2024 Economic Shifts

President Lula to Speak at FII PRIORITY Rio de Janeiro Summit at the Copacabana Palace Wednesday

Globe Newswire

President Lula to Speak at FII PRIORITY Rio de Janeiro Summit at the Copacabana Palace Wednesday

London Research & Pharmaceuticals (LRP) Presents the Advancement of LRP-661, Their Lead Drug Candidate, at the Seventeenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII) Conference in Madrid, Spain, 5-8 May 2024

Globe Newswire

London Research & Pharmaceuticals (LRP) Presents the Advancement of LRP-661, Their Lead Drug Candidate, at the Seventeenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII) Conference in Madrid, Spain, 5-8 May 2024

Unveiling the 8th Future Investment Initiative’s theme: "Infinite Horizons: Investing Today, Shaping Tomorrow"

Globe Newswire

Unveiling the 8th Future Investment Initiative’s theme: "Infinite Horizons: Investing Today, Shaping Tomorrow"

London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulphate drug candidate at the prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII conference in Miami

Globe Newswire

London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulphate drug candidate at the prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII conference in Miami

XEM THÊM TIN MỚI